Position in OCGN
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$31,256
+$15,986 QoQ
Shares Held
20,429
-5.6% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#12
of 35 holders
Holding Since
Jun 2021
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OCGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRINCIPAL FINANCIAL GROUP INC holds $1,874,071,197 across 105 Biotechnology names. OCGN ranks #103 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
873,502 | $232,980,453 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
389,511 | $193,481,798 | |
| 3 | CYTK |
Cytokinetics Inc
|
1,311,664 | $111,740,655 | |
| 4 | GPCR |
Structure Therapeutics Inc.
|
1,752,753 | $94,070,253 | |
| 5 | INSM |
INSMED Inc
|
856,126 | $91,280,154 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
332,642 | $81,420,782 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
1,024,423 | $76,299,024 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
121,053 | $75,481,386 |
All Filings in OCGN
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $31,256 | 20,429 | Shares | Defined | 2026-08-04 | |
| 2025-03-31 | $15,270 | 21,630 | Shares | Defined | 2025-04-28 | |
| 2024-12-31 | $17,908 | 22,246 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $25,023 | 25,225 | Shares | Defined | 2024-10-31 | |
| 2024-06-30 | $53,577 | 34,566 | Shares | Defined | 2024-07-29 | |
| 2024-03-31 | $97,340 | 59,354 | Shares | Defined | 2024-04-29 | |
| 2023-12-31 | $39,381 | 68,489 | Shares | Defined | 2024-02-07 | |
| 2023-09-30 | $24,704 | 61,761 | Shares | Defined | 2023-11-02 | |
| 2023-06-30 | $33,536 | 61,761 | Shares | Defined | 2023-08-07 | |
| 2023-03-31 | $51,750 | 60,669 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $84,676 | 65,136 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $96,542 | 54,238 | Shares | Defined | 2022-11-09 | |
| 2022-06-30 | $126,284 | 55,632 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $185,872 | 56,325 | Shares | Defined | 2022-05-09 | |
| 2021-12-31 | $251,113 | 55,190 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $546,268 | 76,082 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $585,731 | 72,943 | Shares | Defined | 2021-08-10 | |
| No filing history on record for this holder in this stock. | ||||||